# Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

> **NCT07118566** · PHASE2 · NOT_YET_RECRUITING · sponsor: **China Medical University, China** · enrollment: 40 (estimated)

## Conditions studied

- Gastrointestinal Cancer
- Immunotherapy
- Liver Metastasis

## Interventions

- **PROCEDURE:** Hyperthermia
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT07118566
- **Lead sponsor:** China Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2029-05
- **Final completion:** 2029-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07118566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07118566, "Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07118566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*